Inventor · disambiguated record
Daniel Meibom
Also filed as: MEIBOM DANIEL
25 granted patents·14 pending applications·117 citations·filing 2007–2025
94Inventor score
Top patents by PatentIndex Score
39 records- 0191US8889700B24-(4-cyano-2-thioaryl)dihydropyrimidinones and their useVON NUSSBAUM FRANZ·Filed 2012·Granted Nov 18, 2014·19 cites·14 claims
- 0288US8426602B2Heteroaryl-substituted dicyanopyridines and their useMEIBOM DANIEL·Filed 2009·Granted Apr 23, 2013·24 cites·5 claims
- 0386US8580800B21,4-diaryl-pyrimidopyridazine-2,5-diones and their useVON NUSSBAUM FRANZ·Filed 2009·Granted Nov 12, 2013·12 cites·9 claims
- 0486US8288402B24-(4-cyano-2-thioaryl)dihydropyrimidinones and their useVON NUSSBAUM FRANZ·Filed 2008·Granted Oct 16, 2012·9 cites·9 claims
- 0585US10421742B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2016·Granted Sep 24, 2019·3 cites·9 claims
- 0685US8420825B2Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugsVAKALOPOULOS ALEXANDROS·Filed 2010·Granted Apr 16, 2013·10 cites·29 claims
- 0783US8772498B2Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2013·Granted Jul 8, 2014·5 cites·7 claims
- 0883US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 0982US8440700B2Substituted aryloxazoles and their useNELL PETER·Filed 2008·Granted May 14, 2013·6 cites·5 claims
- 1081US9174997B24-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereofBAYER IP GMBH·Filed 2014·Granted Nov 3, 2015·4 cites·15 claims
- 1180US8691817B2Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereofVON NUSSBAUM FRANZ·Filed 2010·Granted Apr 8, 2014·6 cites·9 claims
- 1280US8569314B2Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPDVON NUSSBAUM FRANZ·Filed 2009·Granted Oct 29, 2013·4 cites·6 claims
- 1377US2025282748A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2025·Application pending·0 cites
- 1475US8741834B2Dipeptoid prodrugs and the use thereofLERCHEN HANS-GEORG·Filed 2009·Granted Jun 3, 2014·2 cites·8 claims
- 1571US9040566B2Adenosine A1 agonists for the treatment of glaucoma and ocular hypertensionKLAR JÜRGEN·Filed 2011·Granted May 26, 2015·2 cites·11 claims
- 1671US2023024752A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1767US11180471B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2019·Granted Nov 23, 2021·0 cites·67 claims
- 1858US2014296515A1Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 1957US2010010024A1Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertensionBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 2054US9205077B22-alkoxy-substituted dicyanopyridines and their useBAYER IP GMBH·Filed 2014·Granted Dec 8, 2015·0 cites·8 claims
- 2154US8791146B22-alkoxy-substituted dicyanopyridines and their useHübsch Walter·Filed 2009·Granted Jul 29, 2014·0 cites·9 claims
- 2253US9359362B2Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPDBAYER IP GMBH·Filed 2013·Granted Jun 7, 2016·0 cites·12 claims
- 2353US9095582B2Substituted aryloxazoles and their useBAYER IP GMBH·Filed 2013·Granted Aug 4, 2015·0 cites·5 claims
- 2453US2011237629A1Amino acid ester prodrugs and the use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2552US10479765B2Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agentsBayer Pharma AG·Filed 2018·Granted Nov 19, 2019·0 cites·10 claims
- 2651US9187428B2Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2011·Granted Nov 17, 2015·0 cites·5 claims
- 2750US8618119B2Fused cyanopyridines and the use thereofNELL PETER·Filed 2008·Granted Dec 31, 2013·0 cites·9 claims
- 2850US2011021487A1Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their useBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2949US2012058983A1Adenosine A1 agonists for the treatment of glaucoma and ocular hypertensionKLAR JUERGEN·Filed 2011·Application pending·0 cites
- 3047US8609686B2Substituted azabicyclic compounds and the use thereofNELL PETER·Filed 2008·Granted Dec 17, 2013·0 cites·10 claims
- 3147US2015306084A1Adenosine a1 agonists for the treatment of glaucoma and ocular hypertensionBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 3246US2020339567A1Substituted imidazopyridine amides and use thereofBAYER AG·Filed 2018·Application pending·0 cites
- 3346US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 3445US12398120B2Substituted hydantoinamides as ADAMTS7 antagonistsBAYER AG·Filed 2020·Granted Aug 26, 2025·0 cites·17 claims
- 3545US2016311812A1Adenosine a1 agonists as medicaments for kidney disordersBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3645US2023027985A1Substituted hydantoinamides as adamts7 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 3743US10189788B2Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agentsBayer Pharma AG·Filed 2015·Granted Jan 29, 2019·0 cites·11 claims
- 3841US2016130230A1Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2015·Application pending·0 cites
- 3936US2018155336A1Process for the preparation of 2-{4-[2-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-3,5-dicyan0-6-(pyrrolidin-1-yl)pyridin-4-yl]phenoxy}ethyl-l-alanyl-l-alaninate monohydrochlorideBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Meibom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →